Interestingly, TRIP13 (thyroid hormone receptor interactor 13) characterized by DepMap as Strongly Selective was critical for the maintenance of several cancer cell lines including B-cell lymphoma OCILY19 and Human eosinophilic leukemia EOL1. Here, TRIP13 is linked to B-cell non-Hodgkin lymphoma.